4//SEC Filing
CRUTCHFIELD BRADFORD 4
Accession 0001567619-22-001197
CIK 0001770787other
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 4:32 PM ET
Size
22.8 KB
Accession
0001567619-22-001197
Insider Transaction Report
Form 4
CRUTCHFIELD BRADFORD
Chief Commercial Officer
Transactions
- Sale
Class A Common Stock
2022-01-12$119.28/sh−1,017$121,311→ 102,256 total - Sale
Class A Common Stock
2022-01-12$122.94/sh−100$12,294→ 97,856 total - Sale
Class A Common Stock
2022-01-12$124.44/sh−100$12,444→ 97,656 total - Sale
Class A Common Stock
2022-01-12$125.00/sh−3$375→ 97,653 total - Sale
Class A Common Stock
2022-01-12$117.53/sh−6,195$728,071→ 108,458 total - Sale
Class A Common Stock
2022-01-12$118.32/sh−5,185$613,499→ 103,273 total - Sale
Class A Common Stock
2022-01-12$121.77/sh−3,200$389,648→ 97,956 total - Sale
Class A Common Stock
2022-01-12$123.53/sh−100$12,353→ 97,756 total - Exercise/Conversion
Class A Common Stock
2022-01-12$1.16/sh+17,000$19,720→ 114,653 total - Sale
Class A Common Stock
2022-01-12$120.93/sh−1,100$133,025→ 101,156 total - Exercise/Conversion
Stock Option (right to buy)
2022-01-12−17,000→ 409,000 totalExercise: $1.16Exp: 2027-02-03→ Class A Common Stock (17,000 underlying)
Footnotes (7)
- [F1]The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $116.89 to $117.87. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]This transaction was executed in multiple trades at prices ranging from $117.90 to $118.84. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F4]This transaction was executed in multiple trades at prices ranging from $118.985 to $119.83. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F5]This transaction was executed in multiple trades at prices ranging from $120.31 to $121.29. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F6]This transaction was executed in multiple trades at prices ranging from $121.47 to $122.35. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F7]This option, originally for 800,000 shares, of which 391,000 shares have been exercised, vested as to one-fourth of the shares on February 2, 2018 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
Documents
Issuer
10x Genomics, Inc.
CIK 0001770787
Entity typeother
Related Parties
1- filerCIK 0001246406
Filing Metadata
- Form type
- 4
- Filed
- Jan 13, 7:00 PM ET
- Accepted
- Jan 14, 4:32 PM ET
- Size
- 22.8 KB